Skip to main content
. 2018 Sep 10;2018(9):CD007287. doi: 10.1002/14651858.CD007287.pub4

NCT01584115.

Trial name or title Clinical trial of therapeutic vaccine with NY‐ESO‐1 in combination with the adjuvant monophosphoryl lipid A (MPLA)
Methods Uncontrolled phase I/II
Participants 15 participants with a NY‐ESO‐1‐expressing malignancy after standard treatment
Interventions Intramuscular injection with NY‐ESO‐1 combined with MPLA vaccine
Outcomes Adverse events
Immune responses
Starting date July 2012
Contact information  
Notes Status unknown